2025 HCPCS Code Q0180
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
TAGS: prescription chemotherapy exceed substitute regimen approved therapeutic complete dosage dolasetronShort Description | Dolasetron mesylate oral |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | April 01, 1998 |
HCPCS Action Effective Date | April 01, 1998 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4181 - Amnio wound, per square cm
- Q4182 - Transcyte, per sq centimeter
- Q4183 - Surgigraft, 1 sq cm
- Q4184 - Cellesta or duo per sq cm
- Q4185 - Cellesta flowab amnion 0.5cc
- Q4186 - Epifix 1 sq cm
- Q4187 - Epicord 1 sq cm
- Q4188 - Amnioarmor 1 sq cm
- Q4189 - Artacent ac, 1 mg
- Q4190 - Artacent ac 1 sq cm
- Q4191 - Restorigin 1 sq cm
- Q4192 - Restorigin, 1 cc
- Q4193 - Coll-e-derm 1 sq cm
- Q4194 - Novachor 1 sq cm
- Q4195 - Puraply 1 sq cm
- Q4196 - Puraply am 1 sq cm
- Q4197 - Puraply xt 1 sq cm
- Q4198 - Genesis amnio membrane 1sqcm
- Q4199 - Cygnus matrix, per sq cm
- Q4200 - Skin te 1 sq cm